4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics
20 avr. 2021 09h00 HE
|
4Bio Capital
Press Release 4BIO Capital Co-leads $10 Million Seed Financing in Code Biotherapeutics 20 April 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital...
4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round
01 mars 2021 08h08 HE
|
4Bio Capital
Press Release 4BIO Capital Joins Investor Syndicate in CARISMA Therapeutics’ Second Closing of $59 Million Series B Round 1 March 2021 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”),...
4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery
25 janv. 2021 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital’s review of AAV gene therapy clinical trials published in Nature Reviews Drug Discovery Systematic review and meta-analysis of 149 clinical trials of AAV-based gene...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
08 juin 2020 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin
08 juin 2020 02h00 HE
|
4Bio Capital
Press Release 4BIO Capital announces strategic investment from Japanese pharmaceutical company Kyowa Kirin Kyowa Kirin’s first strategic investment into a Venture Capital fund Kyowa Kirin to...
4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A
25 mars 2020 07h03 HE
|
4Bio Capital
Press Release 4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A Pioneering chemogenetics company is one of the first investments from 4BIO Capital’s Ventures II fund 25 March 2020 ...
4BIO Capital raises $50 million in first close of new advanced therapies fund
09 sept. 2019 07h00 HE
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...
4BIO Capital raises $50 million in first close of new advanced therapies fund
09 sept. 2019 02h00 HE
|
4Bio Capital
Press Release 4BIO Capital raises $50 million in first close of new advanced therapies fund 4BIO Ventures II fund solely focused on advanced therapies targeting $150 million final...